Afsaneh Barzi, MD of Keck School of Medicine presents the IDEA (International Duration Evaluation of Adjuvant Chemotherapy) collaboration which investigated the adjuvant oxaliplatin-based therapy for patients with high-risk stage II colorectal cancer.
